Posted On: 06/24/2014 9:48:48 AM
Post# of 30066
JP, thanks for the heads up and link about ototoxicity.
Here are a few thoughts about it.
Paraphrasing from the article:
"Ototoxicity is a condition which affects the ear causing hearing loss and tinnitus. It is caused by the toxic side affects of over 100 classes of drugs and other pharmacological agents. Management emphasis is on prevention, and substitute medication should be used when appropriate as the damage done is irreversible. Scientists and Clinicians are constantly seeking new methods to reduce the affects of ototoxicity".
I'll repost a portion of Gerald's last blog. Under MANF starting with the fourth paragraph:
This is one of the things our Dr. Schwartz has been working on. If MANF can be used to prevent ototoxicity, there are over 100 classes of medications which may become viable for use and commercialization without being "substituted". And in Gerald's blog it specifically states they are seeking "antibiotic-induced ototoxicity"-we all know of the growing demand for new types of antibiotics. They are also seeking a orphan indication. This small aspect of AMBS's initiatives could become a massive division within AMBS itself!
AMBS looks better and better every day!
GLTA,
GO AMBS
Here is a link to the article if you would like to read more about it.
http://emedicine.medscape.com/article/857679-overview
Here are a few thoughts about it.
Paraphrasing from the article:
"Ototoxicity is a condition which affects the ear causing hearing loss and tinnitus. It is caused by the toxic side affects of over 100 classes of drugs and other pharmacological agents. Management emphasis is on prevention, and substitute medication should be used when appropriate as the damage done is irreversible. Scientists and Clinicians are constantly seeking new methods to reduce the affects of ototoxicity".
I'll repost a portion of Gerald's last blog. Under MANF starting with the fourth paragraph:
Quote:
The Company is also continuing to move forward with other initiatives on the MANF front with Dr. Larry Schwartz at the University of Massachusetts, including the further evaluation of MANF as a treatment for the orphan indication antibiotic-induced ototoxicity, as well as other undisclosed possibilities. - See more at: http://www.thechairmansblog.com/amarantus-bio...q8HoO.dpuf
This is one of the things our Dr. Schwartz has been working on. If MANF can be used to prevent ototoxicity, there are over 100 classes of medications which may become viable for use and commercialization without being "substituted". And in Gerald's blog it specifically states they are seeking "antibiotic-induced ototoxicity"-we all know of the growing demand for new types of antibiotics. They are also seeking a orphan indication. This small aspect of AMBS's initiatives could become a massive division within AMBS itself!
AMBS looks better and better every day!
GLTA,
GO AMBS
Here is a link to the article if you would like to read more about it.
http://emedicine.medscape.com/article/857679-overview
(0)
(0)
